{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:22:54Z","timestamp":1782314574506,"version":"3.54.5"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007197","name":"USPHS","doi-asserted-by":"publisher","award":["NS034153"],"award-info":[{"award-number":["NS034153"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007656","name":"Loyola University Chicago Intramural Grant","doi-asserted-by":"publisher","award":["LU201328"],"award-info":[{"award-number":["LU201328"]}],"id":[{"id":"10.13039\/100007656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012617","name":"Arthur J. Schmitt Foundation Fellowship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.neuropharm.2018.07.008","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T01:05:41Z","timestamp":1531271141000},"page":"173-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["5-HT1A receptor-mediated activation of neuroendocrine responses and multiple protein kinase pathways in the peripubertal rat hypothalamus"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-0457","authenticated-orcid":false,"given":"Maureen L.","family":"Petrunich-Rutherford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2018.07.008_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jemermed.2015.04.032","article-title":"Acute vilazodone toxicity in a pediatric patient","volume":"49","author":"Acker","year":"2015","journal-title":"J.\u00a0Emerg. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.07.008_bib2","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1046\/j.1471-4159.1999.721489.x","article-title":"Agonist stimulation of the serotonin1A receptor causes suppression of anoxia-induced apoptosis via mitogen-activated protein kinase in neuronal HN2-5 cells","volume":"72","author":"Adayev","year":"1999","journal-title":"J.\u00a0Neurochem."},{"issue":"23","key":"10.1016\/j.neuropharm.2018.07.008_bib3","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.2174\/13816128113196660740","article-title":"Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity","volume":"20","author":"Albert","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"issue":"199","key":"10.1016\/j.neuropharm.2018.07.008_bib4","article-title":"Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression","volume":"8","author":"Albert","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"5697","key":"10.1016\/j.neuropharm.2018.07.008_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1101678","article-title":"Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice","volume":"306","author":"Ansorge","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.07.008_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2013.05.030","article-title":"Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats","volume":"73","author":"Arrant","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2018.07.008_bib7","first-page":"277","article-title":"Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH\/corticosterone responses","volume":"73","author":"Bagdy","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.brainresrev.2007.04.005","article-title":"The stress system in depression and neurodegeneration: focus on the human hypothalamus","volume":"57","author":"Bao","year":"2008","journal-title":"Brain Res. Rev."},{"issue":"26633","key":"10.1016\/j.neuropharm.2018.07.008_bib9","article-title":"Selective serotonin 5-HT 1A receptor biased agonists elicit distinct brain activation patterns: a pharmacoMRI study","volume":"6","author":"Becker","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.neuropharm.2018.07.008_bib10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bdi.12023","article-title":"Glycogen synthase kinase-3 levels and phosphorylation undergo large fluctuations in mouse brain during development","volume":"14","author":"Beurel","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(03)01285-8","article-title":"Neuroendocrine pharmacology of stress","volume":"463","author":"Carrasco","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.07.008_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.neuropharm.2018.07.008_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(02)02297-5","article-title":"5-HT1A receptor-mediated regulation of mitogen-activated protein kinase phosphorylation in rat brain","volume":"452","author":"Chen","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2018.07.008_bib14","doi-asserted-by":"crossref","first-page":"18474","DOI":"10.3390\/ijms160818474","article-title":"Functional selectivity and antidepressant activity of serotonin 1A receptor ligands","volume":"16","author":"Chilmonczyk","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.mp.4001897","article-title":"Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine","volume":"12","author":"Conti","year":"2007","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.07.008_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1471-4159.2005.03107.x","article-title":"5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons","volume":"93","author":"Cowen","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2007.07.101","article-title":"5-HT(1A) receptors mediate (+)8-OH-DPAT-stimulation of extracellular signal-regulated kinase (MAP kinase) in\u00a0vivo in rat hypothalamus: time dependence and regional differences","volume":"1183","author":"Crane","year":"2007","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.07.008_bib18","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/PEC.0000000000001174","article-title":"Seizures after pediatric vilazodone ingestion: a case series","volume":"34","author":"Del Pizzo","year":"2018","journal-title":"Pediatr. Emerg. Care"},{"issue":"5","key":"10.1016\/j.neuropharm.2018.07.008_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.biopsych.2006.05.047","article-title":"A\u00a0role for MAP kinase signaling in behavioral models of depression and antidepressant treatment","volume":"61","author":"Duman","year":"2007","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.07.008_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/cap.2017.0047","article-title":"A\u00a06-month open-label extension study of vortioxetine in pediatric patients with depressive or anxiety disorders","volume":"28","author":"Findling","year":"2018","journal-title":"J.\u00a0Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuroscience.2015.05.076","article-title":"Disruption of 5-HT1A function in adolescence but not early adulthood leads to sustained increases of anxiety","volume":"321","author":"Garcia-Garcia","year":"2016","journal-title":"Neuroscience"},{"issue":"43","key":"10.1016\/j.neuropharm.2018.07.008_bib22","doi-asserted-by":"crossref","first-page":"13716","DOI":"10.1021\/bi961764n","article-title":"Ras-dependent activation of fibroblast mitogen-activated protein kinase by 5-HT1A receptor via a G protein beta gamma-subunit-initiated pathway","volume":"35","author":"Garnovskaya","year":"1996","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.neuropharm.2018.07.008_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15563650.2017.1347263","article-title":"Evaluation of dose and outcomes for pediatric vilazodone ingestions","volume":"56","author":"Gaw","year":"2018","journal-title":"Clin. Toxicol."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.07.008_bib24","first-page":"620","article-title":"Selective serotonin re-uptake inhibitors\u2013a review of the side effects in adolescents","volume":"42","author":"Gordon","year":"2013","journal-title":"Aust. Fam. Physician"},{"issue":"4","key":"10.1016\/j.neuropharm.2018.07.008_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biopsych.2007.07.016","article-title":"Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression","volume":"63","author":"Gourley","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.psych.093008.100321","article-title":"Stress hormone regulation: biological role and translation into therapy","volume":"61","author":"Holsboer","year":"2010","journal-title":"Annu. Rev. Psychol."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.07.008_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1471-4159.2003.01987.x","article-title":"Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase","volume":"87","author":"Hsiung","year":"2003","journal-title":"J.\u00a0Neurochem."},{"issue":"6","key":"10.1016\/j.neuropharm.2018.07.008_bib28","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1471-4159.2005.03496.x","article-title":"Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-kappaB-dependent cell survival after serotonin 1A receptor activation","volume":"95","author":"Hsiung","year":"2005","journal-title":"J.\u00a0Neurochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.07.008_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neulet.2011.09.047","article-title":"Effects of chronic social defeat stress on MAP kinase cascade","volume":"504","author":"Iio","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuroscience.2014.04.046","article-title":"Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice","volume":"272","author":"Islam","year":"2014","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2018.07.008_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1210\/en.2010-0658","article-title":"Stress vulnerability during adolescent development in rats","volume":"152","author":"Jankord","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2018.07.008_bib32","series-title":"2007 Neuroscience Meeting Planner","article-title":"SSRI-induced desensitization of hypothalamic 5-HT1A receptor-mediated neuroendocrine responses requires activation of MAP kinase (MEK\/ERK) pathways","author":"Jia","year":"2007"},{"key":"10.1016\/j.neuropharm.2018.07.008_bib33","first-page":"405736","article-title":"Chronic administration of 5-HT1A receptor agonist relieves depression and depression-induced hypoalgesia","author":"Jiang","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib34","first-page":"266","article-title":"Studies on the neuroendocrine role of serotonin","volume":"54","author":"Jorgensen","year":"2007","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1460-9568.2005.03904.x","article-title":"Coupling of 5-HT1A autoreceptors to inhibition of mitogen-activated protein kinase activation by G\u03b2\u03b3 subunit signaling","volume":"21","author":"Kushwaha","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.07.008_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neures.2006.07.001","article-title":"Stress induces the expression of heterotrimeric G protein beta subunits and the phosphorylation of PKB\/Akt and ERK1\/2 in rat brain","volume":"56","author":"Lee","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0893-133X(98)00106-7","article-title":"5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge","volume":"20","author":"Lerer","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2018.07.008_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0006-8993(93)90652-4","article-title":"Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats","volume":"630","author":"Li","year":"1993","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.07.008_bib39","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0022-3565(24)36965-4","article-title":"A\u00a0desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors","volume":"282","author":"Li","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib40","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0022-3565(25)21219-8","article-title":"Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist","volume":"279","author":"Li","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.07.008_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-3565(24)35202-4","article-title":"Reduction of 5-hydroxytryptamine (5-HT) 1A-mediated temperature and neuroendocrine responses and 5-HT1A binding sites in 5-HT transporter knockout mice","volume":"291","author":"Li","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"8","key":"10.1016\/j.neuropharm.2018.07.008_bib42","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.npp.1300439","article-title":"In\u00a0vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain","volume":"29","author":"Li","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2018.07.008_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.npp.1300823","article-title":"Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry","volume":"31","author":"Maciag","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.008_bib44","article-title":"Depression and effects of antidepressant drugs on the stress systems","volume":"vol. 15","author":"Modell","year":"2005"},{"key":"10.1016\/j.neuropharm.2018.07.008_bib45","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/tp.2011.58","article-title":"Serotonin 1A receptor-mediated signaling through ERK and PKC\u03b1 is essential for normal synaptogenesis in neonatal mouse hippocampus","volume":"2","author":"Mogha","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.neuropharm.2018.07.008_bib46","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/npp.2009.47","article-title":"Paradoxical anxiogenic response of juvenile mice to fluoxetine","volume":"34","author":"Oh","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2018.07.008_bib47","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1124\/jpet.104.082073","article-title":"5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome","volume":"313","author":"Osei-Owusu","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"6","key":"10.1016\/j.neuropharm.2018.07.008_bib48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1159\/000126332","article-title":"Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat","volume":"56","author":"Pan","year":"1992","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.07.008_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2007.02.017","article-title":"Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment","volume":"104","author":"Papiol","year":"2007","journal-title":"J.\u00a0Affect. Disord."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.07.008_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cellsig.2011.09.009","article-title":"Functional significance of glycogen synthase kinase-3 regulation by serotonin","volume":"24","author":"Polter","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00406-010-0108-z","article-title":"The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention","volume":"260","author":"Pompili","year":"2010","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.13198","article-title":"Neuroprotective arylpiperazine dopaminergic\/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats","author":"Popovic","year":"2015","journal-title":"J.\u00a0Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.07.008_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbr.2006.08.035","article-title":"The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress","volume":"175","author":"Qi","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.07.008_bib54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3565(24)37930-3","article-title":"Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins","volume":"288","author":"Raap","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.07.008_bib55","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1038\/tp.2015.57","article-title":"The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression","volume":"9","author":"Rahn","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2018.07.008_bib56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0163-7258(01)00169-3","article-title":"Multiplicity of mechanisms of serotonin receptor signal transduction","volume":"92","author":"Raymond","year":"2001","journal-title":"Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.07.008_bib57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/15563650.2017.1287375","article-title":"Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications","volume":"55","author":"Russell","year":"2017","journal-title":"Clin. Toxicol."},{"issue":"11","key":"10.1016\/j.neuropharm.2018.07.008_bib58","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/nn.4116","article-title":"5\u2013HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response","volume":"18","author":"Samuels","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib59","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0022-3565(24)39069-X","article-title":"Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus","volume":"294","author":"Serres","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.07.008_bib60","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.20-09-03095.2000","article-title":"Evidence that Gz-proteins couple to hypothalamic 5-HT1A receptors in\u00a0vivo","volume":"20","author":"Serres","year":"2000","journal-title":"J.\u00a0Neurosci."},{"issue":"36","key":"10.1016\/j.neuropharm.2018.07.008_bib61","article-title":"Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions","volume":"5","author":"Shen","year":"2004","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.07.008_bib62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2003.08.007","article-title":"8-OH-DPAT as a 5-HT 7 agonist: phase shifts of the circadian biological clock through increases in cAMP production","volume":"46","author":"Sprouse","year":"2004","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2018.07.008_bib63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00210-004-1005-7","article-title":"Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in\u00a0vivo","volume":"371","author":"Sullivan","year":"2005","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0083-6729(03)01006-9","article-title":"Serotonin and the neuroendocrine regulation of the hypothalamic\u2013pituitary-adrenal axis in health and disease","volume":"66","author":"Sullivan Hanley","year":"2003","journal-title":"Vitam. Horm."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.07.008_bib65","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1037\/0735-7044.120.5.1084","article-title":"Differential responsiveness to fluoxetine during puberty","volume":"120","author":"Taravosh-Lahn","year":"2006","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib66","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11064-007-9518-3","article-title":"Innovative approaches for the treatment of depression: targeting the HPA axis","volume":"33","author":"Thomson","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2018.07.008_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2015.11.038","article-title":"Beta-arrestin1 and 2 differently modulate metabotropic glutamate receptor 7 signaling in rat developmental sevoflurane-induced neuronal apoptosis","volume":"313","author":"Wang","year":"2016","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neuropharm.2018.07.008_bib68","doi-asserted-by":"crossref","first-page":"e35035","DOI":"10.1371\/journal.pone.0035035","article-title":"MAPK signaling determines anxiety in the juvenile mouse brain but depression-like behavior in adults","volume":"7","author":"Wefers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.07.008_bib69","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.psyneuen.2004.02.002","article-title":"HPA axis activation in major depression and response to fluoxetine: a pilot study","volume":"29","author":"Young","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.07.008_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2017.05.020","article-title":"MicroRNA-101 in the ventrolateral orbital cortex (VLO) modulates depressive-like behaviors in rats and targets dual-specificity phosphatase 1 (DUSP1)","volume":"1669","author":"Zhao","year":"2017","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.07.008_bib71","doi-asserted-by":"crossref","first-page":"e97689","DOI":"10.1371\/journal.pone.0097689","article-title":"The different roles of glucocorticoids in the hippocampus and hypothalamus in chronic stress-induced HPA axis hyperactivity","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T17:56:16Z","timestamp":1751738176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818303666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":71,"alternative-id":["S0028390818303666"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.008","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-HT1A receptor-mediated activation of neuroendocrine responses and multiple protein kinase pathways in the peripubertal rat hypothalamus","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}